Articles 2002 -2007

Cottet V, Pariente A, Nalet B, Lafon J, Milan C, Olschwang S, Bonaiti-Pellié C, Faivre J, Bonithon-Kopp C; ANGH Group.
Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors.
Gastroenterology. 2007;133:1086-92

Cadranel JF, Lahmek P, Causse X, Bellaiche G, Bettan L, Fontanges T, Medini A, Henrion J, Chousterman M, Condat B, Hervio P, Periac P, Eugène C, Moindrot H, Grasset D, Nouel O, Pilette C, Szostak-Talbodec N, Cayla JM, Si-Ahmed SN, Dumouchel P, Pariente A, Lesgourgues B, Denis J.

Epidemiology of chronic hepatitis B infection in France: risk factors for significant fibrosis–results of a nationwide survey.

Aliment Pharmacol Ther. 2007;26:565-76

 

Thevenot T, Denis J, Jouannaud V, Monnet E, Renou C, Labadie H, Abdelli N, Nguyen-Khac E, Dumouchel P, Bresson-Hadni S, Chousterman M, DI Martino V, Cadranel JF.
Coeliac disease in chronic hepatitis C: a French multicentre prospective study.
Aliment Pharmacol Ther 2007 ;26:1209-16

 

Thévenot T, Cadranel JF, Di Martino V, Pariente A, Causse X, Renou C, Hagege H, Denis J, Lunel-Fabiani F.

A national French survey on the use of growth factors as adjuvant treatment of chronic hepatitis C.

Hepatology. 2007;45:377-83

 

Lièvre A, Milet J, Carayol J, Le Corre D, Milan C, Pariente A, Nalet B, Lafon J, Faivre J, Bonithon-Kopp C, Olschwang S, Bonaiti-Pellié C, Laurent-Puig P; members of the ANGH group.

Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma.

BMC Cancer. 2006;6:270 

 

Cottet V, Pariente A, Nalet B, Lafon J, Milan C, Olschwang S, Faivre J, Bonaiti-Pellié C, Bonithon-Kopp C; Angh Group.

Low compliance with colonoscopic screening in first-degree relatives of patients with large adenomas.

Aliment Pharmacol Ther. 2006;24:101-9

 

Jouannaud V, Coutarel P, Tossou H, Butel J, Vitte RL, Skinazi F, Blazquez M, Hagège H, Bories C, Rocher P, Belloula D, Latrive JP, Meurisse JJ, Eugène C, Dellion MP, Cadranel JF, Pariente A; Association Nationale des Hépato-Gastroentérologues des Hôpitaux généraux.

Cystic dystrophy of the duodenal wall associated with chronic alcoholic pancreatitis. Clinical features, diagnostic procedures and therapeutic management in a retrospective multicenter series of 23 patients.

Gastroenterol Clin Biol. 2006;30:580-6

 

Wartelle-Bladou C, Arpurt JP, Renou C, Pariente A, Pillon D, Nalet B, Picon M, Glibert A, Chousterman M, Grasset D, Morin T, Bernard P, Fischer D, Ramdani M, Lagier E, Rotily M; Viral Hepatitis Group of the ANGH.

High dose daily interferon-alpha induction and secondary adjunction of ribavirin in treatment-naive patients with chronic hepatitis C. A multicentric, randomised, controlled trial.

Gastroenterol Clin Biol. 2006;30:525-32

 

Barbare JC, Bouché O, Bonnetain F, Raoul JL, Rougier P, Abergel A, Boige V, Denis B, Blanchi A, Pariente A, Milan C, Bedenne L.

Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma.

J Clin Oncol. 2005;23:4338-46

 

Bour B, Staub JL, Chousterman M, Labayle D, Nalet B, Nouel O, Pariente A, Tocque E, Bonnot-Marlier S.

Long-term treatment of gastro-oesophageal reflux disease patients with frequent symptomatic relapses using rabeprazole: on-demand treatment compared with continuous treatment.

Aliment Pharmacol Ther. 2005;21:805-12

 

Pariente A, Djilloul A, Cadranel JF; Association Nationale des Gastroentérologues des Hôpitaux Généraux.

Treatment of chronic hepatitis C with interferon alpha and ribavirin. Results in “real life”

Gastroenterol Clin Biol. 2003;27:590-5

 

Morin T, Pariente A.

Acute hepatitis C: a retrospective study of 62 cases

Gastroenterol Clin Biol. 2002;26:994-1000

 

Renou C, Halfon P, Pol S, Cacoub P, Jouve E, Bronowicki JP, Arpurt JP, Rifflet H, Picon M, Causse X, Canva V, Denis J, Tran A, Bourliére M, Ouzan D, Pariente A, Dantin S, Alric L, Cartier V, Reville M, Caillat-Zucman S.

Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels.

Gut. 2002;51:585-90

 

Moreau R, Durand F, Poynard T, Duhamel C, Cervoni JP, Ichaï P, Abergel A, Halimi C, Pauwels M, Bronowicki JP, Giostra E, Fleurot C, Gurnot D, Nouel O, Renard P, Rivoal M, Blanc P, Coumaros D, Ducloux S, Levy S, Pariente A, Perarnau JM, Roche J, Scribe-Outtas M, Valla D, Bernard B, Samuel D, Butel J, Hadengue A, Platek A, Lebrec D, Cadranel JF.

Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.

Gastroenterology. 2002;122:923-30